Valentina Arsic Arsenijevic

Prof. Valentina Arsic Arsenijevic, MD, Msc, PhD, FECMM is founder and head of the National Reference Laboratory for Medical Mycology and Full university professor at Faculty of Medicine, University of Belgrade, Belgrade, Serbia. She received her academy degrees, Microbiology specialist, and Mycology subspecialist degrees from the same University. She has been a visitor scientist, visiting professor or a research fellowship in University of Ljubljana (Slovenia), Karolinska University (Sweden), University of Innsbruck (Austria), and University of Sassari (Italy).

She is founder of University spinout biotechnology company (MyCoMedlab) and founder and president of Serbian Society of Medical Mycology (SSMM). She serves as Global Action Fund for Fungal Infections (GAFFI) ambassador and Serbian congress ambassador, and collaborator of Global Burden Diseases (GBD) group. She represents SSMM at European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and Fungal Infection Study Group (EFISG), International Society of Human and Animal Mycology (ISHAM), and European Confederation of Medical Mycology (ECMM). She was local organizer of Trends in Medical Mycology – 2017 (TIMM 8) and president of the Executive Board, as well as member of ECMM board (treasurer 2014-2017). She currently serves on the Program Committee of TIMM 2019. She has been a speaker and chair in several national and international conferences.

Prof. Arsic Arsenijevic established and organized six National educational meeting Diagnosis and treatment of fungal diseases (DTFD), and published more than 200 articles in prestigious journals (including the Lancet) or books for University students and medical doctors. She has been a reviewer for numerous medical scientific journals, including Mycoses, in the last 10 years. She established website (1998-) (www.mikologija.org.rs) and (2012) (www.dtfd.org) which attracts about 600,000 visitors yearly.

She had led and participated in over 20 national and international scientific projects. Currently she leads project “Early laboratory biomarker detection and significance for outcome of invasive fungal infections (IFI) in Serbia”. Her research and publications focus is on laboratory diagnosis of IFI, antifungal susceptibility testing, local fungal epidemiology and resistance, modeling of mycological process, innovative approach in personalized medical mycology, and history of Serbian medicine.  Her work has been cited over 8,000 times, and Google scholar H-index is 18.